Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$23.07 - $32.77 $807 - $1,146
-35 Reduced 11.63%
266 $7,000
Q4 2022

Feb 14, 2023

SELL
$25.29 - $35.48 $13,934 - $19,549
-551 Reduced 64.67%
301 $7,000
Q3 2022

Nov 14, 2022

BUY
$24.0 - $33.42 $20,448 - $28,473
852 New
852 $25,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Cary Street Partners Asset Management LLC Portfolio

Follow Cary Street Partners Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Asset Management LLC with notifications on news.